Navigation Links
Millennium Laboratories Announces Laboratory Responsibility Pledge

SAN DIEGO, March 21, 2012 /PRNewswire/ -- Millennium Laboratories announced today the Clinical Laboratory Responsibility Pledge, a declaration setting the course for more responsible and ethical business practices in the medication monitoring industry. The Pledge outlines the principles to which Millennium adheres and to which the company challenges every clinical laboratory in the pain management industry to adopt.


"Ethical practices and compliance are an intrinsic part of Millennium's DNA. Our actions over the past several years to advocate, legislate, and if required, litigate in support of a responsible code of conduct demonstrates this commitment," said Howard Appel, President of Millennium Laboratories. "The time has come, however, to make a public proclamation of our commitment to these standards and to encourage every clinical laboratory in our industry to do the same. The Clinical Laboratory Responsibility Pledge speaks directly to our customers so they know that when they work with Millennium, they work with a company that upholds the highest in ethical standards, compliance and business practices."

The Pledge builds on the Office of Inspector General's Compliance Program for Clinical Laboratories and calls upon all medication monitoring laboratories to join Millennium in immediately taking steps that institute transparency and responsibility through compliance to ethical standards and self-governance.

 These principles include, but are not limited to, the following:

  • adhering to the highest of ethical standards of engagement with our customers to create a positive outcome for patients
  • abiding by each state's specific compliance requirements, regulations and laws
  • not offering a service that would place the healthcare professional, the practice or the patient at risk
  • substantiating claims with valid science and never falsely promoting our products or services 

"These principles should already constitute standard operating procedure for every laboratory in this industry," said Appel. "Unfortunately, they are often disregarded by other laboratories in the pursuit of profit.  As a result, physician practices are put at risk, patient care may be compromised, heath care dollars are wasted, and the industry as a whole is undervalued. Our industry should not – and Millennium will not – idly stand by while these actions continue."

A key component of the Pledge is the adoption of clinical laboratories guidelines to be established by an upcoming stakeholder summit comprised of leading pain and physician associations, regulators and other stakeholders. The summit will be chaired by Dr. Richard Payne, Professor of Medicine and Divinity at Duke University, a highly-respected expert in pain, palliative care and bioethics, who also served as past chair of the American Pain Society.

"The Clinical Laboratory Responsibility Pledge announced by Millennium puts forth excellent examples of ethical initiatives that can lead the medication monitoring industry to a higher level of integrity in business practices and patient care," said Richard Payne, MD.  "I look forward to convening the stakeholders working group as soon as practicable with the purpose of delineating and disseminating an ethical code of conduct broadly accepted by the range of national pain societies; increasing awareness of expected laboratory conduct among physicians and other prescribers, and dramatically reducing the number of unethical practices by those companies seeking an unfair advantage."

The Clinical Laboratory Responsibility Pledge and Millennium's Commitment to Compliance policy are publicly available on the company website at

About Millennium Laboratories:
Millennium Laboratories is the leading research-based clinical diagnostic company dedicated to improving the lives of people suffering from pain. The company provides healthcare professionals with scientific data, clinical tools and services that help personalize treatment plans to improve clinical outcomes and patient safety.

The company utilizes leading technology and proprietary methodologies to provide some of the fastest and most reliable medication monitoring and drug detection results via both urine drug testing (UDT) and oral fluid testing. Test results are backed by expert toxicologists, clinical guidance and dedicated customer service.

Millennium's commitment to advancing the science and the field of pain management also includes a strong focus on the advancement of industry research, education and advocacy.  Through its association with the Millennium Research Institute, a nonprofit national research center , it has quickly gained respect as a leader in toxicology, pharmacology and pain management research and education, providing healthcare professionals with innovative research to advance the assessment and management of chronic pain.

SOURCE Millennium Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium HealthCare Appoints Ed Joyce to Company Advisory Board
2. Millennium Laboratories Sponsors Physician Education on Safe Opioid Prescribing at American Academy of Pain Medicine Annual Meeting
3. Millennium Research Institute Announces 2012 Educational Initiatives
4. Millennium Surgical Corp. Provides Instruments to Latter Day Saints Charities for Humanitarian Projects
5. Millennium HealthCare Developing and Managing First Vascular Ambulatory Surgical Center
6. Millennium HealthCare Inc. Engages KBL, LLP
7. Millennium Surgical Provides Services and Support to CURE Internationals Zambian Surgical Program
8. Now Faster & Easier — Millennium Pharmacy Systems Announces New Release of MPSRx®
9. Zen Holding Corp. Changes Name to Millennium HealthCare Inc.
10. Millennium Laboratories Announces New General Counsel Martin Price and Chief Compliance Officer Janna Sipes
11. Millennium Surgicals Smart Instrument Purchasing Saves OR Personnel Time, Money
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
(Date:6/23/2016)... , June 23, 2016  Experian Health, ... and transforming the patient payment and care ... innovative new products and services that will ... revenue cycle offerings. These award-winning solutions will ... workflows, remain compliant in an ever-changing environment ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):